Navigation Links
Competitor Analysis: Therapeutic Proteins - Biosimilars, Biobetters & Biosuperiors
Date:5/16/2013

es, therapeutic proteins represent a major category of pharmaceutical products with established therapeutic value and high economic attractiveness. As more and more of the branded products are running out of patent protection and regulatory agencies are providing better guidance, development of biosimilar versions as well as of improved next generation versions are a highly attractive goal for pharmaceutical and biotechnology as well as technology focused companies.

 

This report includes a compilation of current active projects in research and development of biosimilar and novel biobetter/biosuperior therapeutic proteins as well as non-protein based competitor products and an overview of approved products in regulated and less regulated markets.

 

Competitor projects are listed in a tabular format providing Information on:

 

• Drug Codes,

• Target / Mechanism of Action,

• Class of Compound,

• Company,

• Product Category,

• Indication,

• R&D Stage and

• additional comments with a hyperlink leading to the source of information.

 

About Competitor Analysis Series:

 

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

 

 

 

Table of Contents

 

1) Erythropoiesis Stimulating Agents (ESA)

 

• First generation epoetins in regulated markets

• Second generation epoetins in regulated markets

• Epoetin biosimilars in regulated markets

• Darbepoetin biosimilars in regulated markets

• Next generation biologic Eythropoiesis Stimulating Agents (ESA) in
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Cell Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
3. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
4. Orexigen Therapeutics Reports Financial Results for the First Quarter Ended March 31, 2013
5. Emergent Technologies and Caisson Biotech Form Strategic Alliance with Local Health Care Providers to Improve Delivery and Performance of a Therapeutic Drug
6. Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
7. Oxford BioTherapeutics and Boehringer Ingelheim Enter Collaboration to Discover Novel Antibody Targets in Cancer
8. Orexigen Therapeutics Commends the Campaign to End Obesitys Report on Long-term Returns of Obesity Prevention Policies
9. Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013
10. United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
11. Nanotherapeutics Awarded Defense Department Contract for Advanced Development and Manufacturing of Medical Countermeasures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Scottsdale, Arizona (PRWEB) January 15, 2014 ... growth for Scottsdale’s Brain State Technologies®. They saw continued ... University Medical Center who were awarded a $1 million ... papers published in “Brain and Behavior” a peer reviewed ...
(Date:1/15/2014)... AudioNotch is the internet's leading provider of Notched Sound ... Patients listen to sound therapy that is tailor-made for ... to months, their tinnitus volume decreases. , AudioNotch has previously ... Notched White Noise. Now, AudioNotch is pleased to announce to ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 Date: ... p.m. , Location: Warrington Country Club, 1360 Almshouse Road, Warrington, ... only national nonprofit organization solely dedicated to finding a cure ... those affected worldwide, will host its annual Crystal Ball on ...
(Date:1/14/2014)... January 14, 2014 Histogen, Inc., a ... of cells grown under simulated embryonic conditions, today announced ... with Suneva Medical, Inc. for physician-dispensed aesthetic products containing ... , This agreement is an amendment to the existing ...
Breaking Biology Technology:Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Hepatitis B Foundation to Host Annual Crystal Ball Gala 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3
... , ... (AAA) are so deadly, they kill 13,000 Americans every year. Minimally invasively emergency repair of ... data. The latest research on AAA is being presented at the 22nd annual International ... ...
... nitride nanotubes (BNNTs) are the divas of the nanoworld. ... temperamental compared to their carbon-based cousins. On the ... over 1,100 degrees Celsius, says Yoke Khin Yap, an ... nanotubes would burn like charcoal in a barbecue at ...
... , FT. LAUDERDALE, Fla. , Jan. 15 ... Green Hedge Fund to provide further investment for the company,s growth ... new level" is how CEO Chris Hamilton views this ... As controlling and ultimately reducing Carbon Emissions feature so highly on ...
Cached Biology Technology:Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 2Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 3Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 4Minimally Invasive Repair of Ruptured Aortic Aneurysm Could Save More Lives than Surgery 5Harnessing the divas of the nanoworld 2InfoSpi to Create $500m Green Hedge Fund Focusing on the Carbon Credit Market 2
(Date:4/24/2014)... - Purdue and West Virginia University researchers are the ... providing a bird,s-eye view of eagle features that could ... study calls into question long-held assumptions about golden eagle ... sensitive to ultraviolet light as previously thought. The genome ... sense of smell than researchers realized. , Additionally, ...
(Date:4/24/2014)... been published in the Scientific Reports journal. , ... (a joint centre of CSIC and Pompeu Fabra University-UPF), explains: ... and we saw that it did not match with the ... sequence the complete genome and to make a functional interpretation ... to Louis XVI". , The functional genome analysis was ...
(Date:4/24/2014)... study representing the largest study of animal intelligence to-date finds ... self-control. , Published this week in the journal Proceedings ... part of a long history of research aimed at understanding ... do things like make and use tools, read social cues, ... Until now, most studies of animal intelligence have focused on ...
Breaking Biology News(10 mins):Genome yields insights into golden eagle vision, smell 2The blood preserved in the pumpkin did not belong to Louis XVI 2Animals with bigger brains, broader diets have better self control 2Animals with bigger brains, broader diets have better self control 3
... This press release is available in German . ... a UFZ German scientist found that the worldwide ... pollinators, bees mainly, was 153 billion in 2005 for ... amounted to 9.5% of the total value of the ...
... been referred to as an "essential toxin" due to ... between the nutritious requirement and toxic effects upon exposure. ... have lead to the characterization of selenium as a ... narrow threshold concentration in ecosystems through anthropogenic activities. Ironically, ...
... Journalists are invited to attend the 20th EORTCNCIAACR ... Geneva, Switzerland [Geneva Palexpo, Geneva] from Tuesday 21 ... is the deadline for booking accommodation via the ... this symposium, organised jointly by the European Organisation ...
Cached Biology News:Economic value of insect pollination worldwide estimated at 153 billion euros 2Economic value of insect pollination worldwide estimated at 153 billion euros 3Biological selenium removal: The solution to pollution? 2Media invitation: 20th EORTC-NCI-ACR Symposium on Molecular Targets and Cancer Therapeutics 2